9 WiSys Technologies in "Pharmaceuticals & Vitamin D" or "Diagnostic Assays"
Reusable Enzyme-Free Glucose Sensor Offers Greater Stability, Longer Shelf-Life and Easier Fabrication
WiSys is currently seeking a strategic partner interested in further developing this non-enzymatic glucose sensor technology, ultimately providing a route to market for its commercialization.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.
UW-Platteville researchers have developed a novel and rapid means of detecting multiple classes of illicit drugs, including synthetic cathinones, cannabinoids and cocaine.
The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.
WiSys is currently seeking a strategic partner to assist in such further development providing a route to market for the commercialization of lead analogues.